Nadia Harbeck, MD, PhD, is Director of the Breast Center, the Center for Hereditary Breast and Ovarian Cancer, and holds the chair for Conservative Oncology at the Deptartment of OB&GYN, LMU University Hospital, Munich, Germany. She obtained her specialist degree (OB&GYN) at the Technical University of Munich (TUM) and her medical degree from the Ludwig-Maximilians-University of Munich (LMU).

Professor Harbeck is the current chair of the ESMO (European Society for Medical Oncology) Early Breast Cancer Faculty; she served as ESMO Director of Education and member of the ESMO Executive Board (2023-2025) as well as Subject Editor of the ESMO Breast Cancer Guidelines (2022-2025). She was a member of the ASCO Annual Meeting Educational Committee (2022-2025). She is a member of the expert panel issuing the German AGO recommendations for breast cancer therapy (www.ago-online.de). She is co-director of the West German Study Group (www.wsg-online.com). From 2009-2015, she served on the EORTC Executive Board as chair of the Translational Research Division. Professor Harbeck is a principal investigator or steering committee member of numerous breast cancer trials, particularly with novel targeted compounds and individualized treatment strategies. She has a strong interest in eHealth and is a co-developer of CANKADO, an international digital patient diary (www.cankado.com).

Professor Harbeck is one of the most frequently cited clinical researchers worldwide (Highly Cited Researcher 2021-2024). She has authored more than 780 papers in peer-reviewed journals (h-index 103) and is coordinating editor-in-chief of Breast Care (Karger Publishers). She co-directed the annual ESMO AACR EORTC Methods in Clinical Cancer Research Workshop (MCCR) from 20218-2019 and 2022-2024 and is a panel member of several international breast cancer consensus conferences.

In 2025, Prof. Harbeck received the Bavarian Order of Merit from the Governor of Bavaria, Germany. She is an Adjunct Professor of the University of Vienna, Austria, and a recipient of the 2023 German Cancer Award and the 2020 ESMO Lifetime Achievement Award. She received several additional recognitions of her clinical and translational research, such as the 2021 UPO Award for Women in Academy and Research, the 2015 Bavarian Cancer Patient Award, the 2012 Claudia von Schilling Award, the 2008 EBCC Award, the 2002 AGO Schmidt-Matthiesen Award, a 2001 AACR Award, and the 2001 ASCO Fellowship Merit Award for the highest ranking abstract.